GLP-1 ANALOGS FOR THE TREATMENT OF OBESITY

被引：0
|
作者：
Sever, M. Jensterle [1 ,2 ]
机构：
[1] Univ Med Ctr Ljubljana, Dept Endocrinol Diabet & Metab Dis, Ljubljana, Slovenia
[2] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
230
引用
收藏
页码：A6 / A6
页数：1
相关论文
共 50 条
  • [31] GLP-1 receptor agonists for the treatment of obstructive sleep apnea and obesity
    Romariz, Livia
    Araujo, Beatriz
    Barbosa, Lucas M.
    Jain, Riddhi
    Porto Silva Janovsky, Carolina C.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2025, 132 : 153 - 155
  • [32] Discovery of Insulin/GLP-1/Glucagon Triagonists for the Treatment of Diabetes and Obesity
    Huang, Chunhui
    Palani, Anandan
    Yang, Zhiqiang
    Deng, Qiaolin
    Reddy, Vijay
    Nargund, Ravi P.
    Lin, Songnian
    Altezza, Simona
    Bianchi, Elisabetta
    Orvieto, Federica
    Carrington, Paul
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, : 1255 - 1261
  • [33] GLP-1, GIP, and Glucagon Agonists for Obesity Treatment: A Hunger Perspective
    D'Avila, Mateus
    Hall, Samantha
    Horvath, Tamas L.
    ENDOCRINOLOGY, 2024, 165 (11)
  • [34] GLP-1 receptor agonists for the treatment of obesity: Role as a promising approach
    Wang, Jing-Yue
    Wang, Quan-Wei
    Yang, Xin-Yu
    Yang, Wei
    Li, Dong-Rui
    Jin, Jing-Yu
    Zhang, Hui-Cong
    Zhang, Xian-Feng
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [35] What Is GLP-1 Really Doing in Obesity?
    Hira, Tohru
    Pinyo, Jukkrapong
    Hara, Hiroshi
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2020, 31 (02): : 71 - 80
  • [36] GLP-1 physiology informs the pharmacotherapy of obesity
    Drucker, Daniel J.
    MOLECULAR METABOLISM, 2022, 57
  • [37] GLP-1 analogues in obesity: a cautionary tale
    Derrien, Elisa
    ACTUALITES PHARMACEUTIQUES, 2024, 63 (640):
  • [38] Pairing up with GLP-1 to combat obesity
    Crunkhorn, Sarah
    NATURE REVIEWS DRUG DISCOVERY, 2025, 24 (02) : 89 - 89
  • [39] The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity
    Crane, James
    McGowan, Barbara
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2016, 7 (02) : 92 - 107
  • [40] The benefits of GLP-1 drugs beyond obesity
    Drucker, Daniel J.
    SCIENCE, 2024, 385 (6706) : 258 - 260
12345